Biolase (BIOL) Misses Q1 EPS by 5c

Biolase (NASDAQ: BIOL) reported Q1 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $10.3 million versus the consensus estimate of $10.43 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• SanDisk upgraded at JPMorgan after investor day; shares climb